<SEC-DOCUMENT>0001398344-25-011237.txt : 20250604
<SEC-HEADER>0001398344-25-011237.hdr.sgml : 20250604
<ACCEPTANCE-DATETIME>20250604124641
ACCESSION NUMBER:		0001398344-25-011237
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250604
DATE AS OF CHANGE:		20250604

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NovaBay Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001389545
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				680454536
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-83670
		FILM NUMBER:		251022532

	BUSINESS ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		(510) 899-8800

	MAIL ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			POPLAR POINT CAPITAL MANAGEMENT LLC
		CENTRAL INDEX KEY:			0001588273
		ORGANIZATION NAME:           	
		EIN:				460530967
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D

	BUSINESS ADDRESS:	
		STREET 1:		330 PRIMROSE ROAD, SUITE 400
		CITY:			BURLINGAME
		STATE:			CA
		ZIP:			94010
		BUSINESS PHONE:		650-239-9049

	MAIL ADDRESS:	
		STREET 1:		330 PRIMROSE ROAD, SUITE 400
		CITY:			BURLINGAME
		STATE:			CA
		ZIP:			94010
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: POPLAR POINT CAPITAL MANAGEMENT LLC -->
          <cik>0001588273</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common Stock, par value $0.01 per share</securitiesClassTitle>
      <dateOfEvent>06/03/2025</dateOfEvent>
      <previouslyFiledFlag>true</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001389545</issuerCIK>
        <issuerCUSIP>66987P409</issuerCUSIP>
        <issuerName>Novabay Pharmaceuticals, Inc.</issuerName>
        <address>
          <com:street1>2000 POWELL STREET, SUITE 1150</com:street1>
          <com:city>Emeryville</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94608</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Jad Fakhry</personName>
          <personPhoneNum>650-239-9049</personPhoneNum>
          <personAddress>
            <com:street1>330 Primrose Road</com:street1>
            <com:street2>Suite 400</com:street2>
            <com:city>Burlingame</com:city>
            <com:stateOrCountry>CA</com:stateOrCountry>
            <com:zipCode>94010</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001588273</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Poplar Point Capital Management LLC</reportingPersonName>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>1020300.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>1020300.00</sharedDispositivePower>
        <aggregateAmountOwned>1020300.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>17.54</percentOfClass>
        <typeOfReportingPerson>IA</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001588289</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Poplar Point Capital Partners LP</reportingPersonName>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>1020300.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>1020300.00</sharedDispositivePower>
        <aggregateAmountOwned>1020300.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>17.54</percentOfClass>
        <typeOfReportingPerson>PN</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001588288</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Poplar Point Capital GP LLC</reportingPersonName>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>1020300.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>1020300.00</sharedDispositivePower>
        <aggregateAmountOwned>1020300.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>17.54</percentOfClass>
        <typeOfReportingPerson>HC</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001588217</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Jad Fakhry</reportingPersonName>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>1020300.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>1020300.00</sharedDispositivePower>
        <aggregateAmountOwned>1020300.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>17.54</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock, par value $0.01 per share</securityTitle>
        <issuerName>Novabay Pharmaceuticals, Inc.</issuerName>
        <issuerPrincipalAddress>
          <com:street1>2000 POWELL STREET, SUITE 1150</com:street1>
          <com:city>Emeryville</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94608</com:zipCode>
        </issuerPrincipalAddress>
        <commentText>The securities to which this statement on Schedule 13D relates are the shares with par value of $0.01 for NovaBay Pharmaceuticals, LLC.  The address of the principal executive office of the Issuer is 2000 Powell Street, Suite 1150, Emeryville, CA, Emeryville.</commentText>
      </item1>
      <item2>
        <filingPersonName>(i) Poplar Point Capital Management LLC ("PPCM"), is a Delaware limited liability company;

(ii) Poplar Point Capital Partners LP ("PPCP"), is a Delaware limited partnership;

(iii) Poplar Point Capital GP LLC ("PPCGP"), is a Delaware limited liability company;

(iv) Jad Fakhry ("Mr. Fakhry"), a United States citizen (collectively with PPCM, PPCP and PPCGP, the "Reporting Persons").

PPCM is the investment manager for PPCP.  PPCGP is the general partner of PPCP.  Mr. Fakhry is the manager of, and owns a controlling interest in, PPCM and PPCGP.</filingPersonName>
        <principalBusinessAddress>The address of the principal business and principal office of each of the Reporting Persons is:

330 Primrose Road, Suite 400
Burlingame, CA 94010</principalBusinessAddress>
        <principalJob>The principal business of the Reporting Persons is investing securities.

The principal occupation of Mr. Fakhry is serving as the Manager of Poplar Point.</principalJob>
        <hasBeenConvicted>During the past five years, none of the Reporting Persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).</hasBeenConvicted>
        <convictionDescription>During the past five years, none of the Reporting Persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding such person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.</convictionDescription>
        <citizenship>PPCM is a Delaware limited liability company.
PPCP is a Delaware limited partnership.
PPCGP is a Delaware limited liability company.
Mr. Fakhry is a citizen of the United States of America.</citizenship>
      </item2>
      <item3>
        <fundsSource>PPCM directly holds 1,020,300 shares of Common Stock.  Consideration for these assets came from working capital of PPCM.</fundsSource>
      </item3>
      <item4>
        <transactionPurpose>The purpose of the acquisition of the Common Stock is for investment, and the acquisitions of the Common Stock were made in the ordinary course of business.  Given the Reporting Persons' ownership percentage of the Issuer, the Reporting Persons holding of the Common Stock may have the purpose or effect of control.

At this time, the Reporting Persons have no specific plan or proposal to acquire additional Common Stock or dispose of the Common Stock.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>(i) PPCM
1,020,300
17.54%

(ii) PPCP
1,020,300
17.54%

(iii) PPCGP
1,020,300
17.54%

(iv) Jad Fakhry
1,020,300
17.54%</percentageOfClassSecurities>
        <numberOfShares>(i) PPCM
Sole Voting Power - 0
Shared Voting Power - 1,020,300
Sole Dispositive Power - 0
Shared Dispositive Power - 1,020,300

(ii) PPCP
Sole Voting Power - 0
Shared Voting Power - 1,020,300
Sole Dispositive Power - 0
Shared Dispositive Power - 1,020,300

(iii) PPCGP
Sole Voting Power - 0
Shared Voting Power - 1,020,300
Sole Dispositive Power - 0
Shared Dispositive Power - 1,020,300

(iv) Jad Fakhry
Sole Voting Power - 0
Shared Voting Power - 1,020,300
Sole Dispositive Power - 0
Shared Dispositive Power - 1,020,300</numberOfShares>
        <transactionDesc>In the past 60 days, the following transactions were effected by the Reporting Persons, in normal course of business:
4/4/2025 - Purchased 4,538 shares of Common Stock at a price of $0.5216.
4/8/2025 - Purchased 300 shares of Common Stock at a price of $0.4650.</transactionDesc>
        <listOfShareholders>No other person is known to the Reporting Persons to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock covered by this Statement.</listOfShareholders>
        <date5PercentOwnership>Not applicable.</date5PercentOwnership>
      </item5>
      <item6>
        <contractDescription>Other than as described herein, to the knowledge of the Reporting Persons, there are no contracts, arrangements, understandings or relationships, legal or otherwise, among the Reporting Persons or between the Reporting Persons and any other persons with respect to any securities of the Issuer, including but not limited to transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.</contractDescription>
      </item6>
      <item7>
        <filedExhibits>JOINT FILING AGREEMENT The undersigned hereby agree to jointly prepare and file with regulatory authorities this Schedule 13D and any future amendments thereto reporting each of the undersigned's ownership of securities of the Issuer named herein, and hereby affirm that such Schedule 13D is being filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

Dated this 4th day of June, 2025

POPLAR POINT CAPITAL MANAGEMENT LLC
By: /s/ Jad Fakhry
Jad Fakhry, Manager

POPLAR POINT CAPITAL PARTNERS LP
By: Poplar Point Capital GP LLC its General Partner
By: /s/ Jad Fakhry
Jad Fakhry, Manager

POPLAR POINT CAPITAL GP LLC
By: /s/ Jad Fakhry
Jad Fakhry, Manager

/s/ Jad Fakhry
JAD FAKHRY, an individual</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Poplar Point Capital Management LLC</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Jad Fakry</signature>
          <title>Jad Fakhry, Manager</title>
          <date>06/04/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Poplar Point Capital Partners LP</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Jad Fakry</signature>
          <title>Jad Fakhry, Manager</title>
          <date>06/04/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Poplar Point Capital GP LLC</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Jad Fakry</signature>
          <title>Jad Fakhry, Manager</title>
          <date>06/04/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Jad Fakhry</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Jad Fakry</signature>
          <title>Jad Fakhry</title>
          <date>06/04/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
